Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
Daniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Scientific Reports
|
December 26, 2019
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
Nicholas Willumsen, Suhail M Ali, Kim Leitzel, et al.
Breast Cancer Research and Treatment
|
May 10, 2017
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)
Diep Ho, Jessica Huang, Judith-Anne W Chapman, et al.
Cancer
|
May 3, 2017
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27
Allan Lipton, Judith-Anne W Chapman, Kim Leitzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases
Allan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2012
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials
Allan Lipton, Karim Fizazi, Alison T Stopeck, et al.
Calcified Tissue International
|
June 20, 2018
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis
Evelyne Gineyts, Nicolas Bonnet, Cindy Bertholon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy
Allan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2015
Hypocalcaemia in patients with metastatic bone disease treated with denosumab
Jean-Jacques Body, Henry G Bone, Richard H de Boer, et al.
Cancer Research
|
February 18, 2011
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers
Ritwik Ghosh, Archana Narasanna, Shizhen Emily Wang, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
Daniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Scientific Reports
|
December 26, 2019
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
Nicholas Willumsen, Suhail M Ali, Kim Leitzel, et al.
Breast Cancer Research and Treatment
|
May 10, 2017
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)
Diep Ho, Jessica Huang, Judith-Anne W Chapman, et al.
Cancer
|
May 3, 2017
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27
Allan Lipton, Judith-Anne W Chapman, Kim Leitzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases
Allan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2012
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials
Allan Lipton, Karim Fizazi, Alison T Stopeck, et al.
Calcified Tissue International
|
June 20, 2018
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis
Evelyne Gineyts, Nicolas Bonnet, Cindy Bertholon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy
Allan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2015
Hypocalcaemia in patients with metastatic bone disease treated with denosumab
Jean-Jacques Body, Henry G Bone, Richard H de Boer, et al.
Cancer Research
|
February 18, 2011
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers
Ritwik Ghosh, Archana Narasanna, Shizhen Emily Wang, et al.
Page
of 15